MedTrace Logo

Clinical Evaluation of Soft Tissue Augmentation Using CTG and PRF Around Immediately Placed Dental Implants Versus Immediate Implant Alone in Esthetic Zone .

NCT03413553 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2021-08-03

No results posted yet for this study

Summary

The main hypothesis to be certified is that the addition of Subepithelial Connective Tissue Graft (SCTG) and Platelet rich Fibrin (PRF) to immediately placed implants will not significantly differ from immediately placed implant alone as regard gingival tissue stability.

Conditions

  • Soft Tissue Augmentation

Interventions

DEVICE

immediate implant

Patient will receive immediate implant alone.

BIOLOGICAL

connective tissue graft

patient will receive immediate implant with connective tissue graft and platelet rich fibrin

BIOLOGICAL

platelet rich fibrin

patient will recieve immediate implant combined with connective tissue graft and platelet rich fibrin

Sponsors & Collaborators

  • Cairo University

    collaborator OTHER

  • Abeer hassan sharafuddin

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2019-09-30
Completion
2020-01-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03413553 on ClinicalTrials.gov